Announced
Financials
Tags
pharmaceutical
Pending
Public
Friendly
Pharmaceuticals
Acquisition
Majority
Single Bidder
Cross Border
Singapore
Synopsis
Jinhushen Biological Medical Science and Technology, a China-incorporated company that is in the business of technical research and development of biological and chemical products, agreed to acquire a 67% stake in TIANJIN Zhong Xin Pharmaceutical Group, a cardiovascular and respiratory medicines provider. Financial terms were not disclosed.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.